COMMENTARY: An early invasive strategy was not better than a selectively invasive strategy for acute coronary syndromes

Welsford, Michelle
March 2006
ACP Journal Club;Mar/Apr2006, Vol. 144 Issue 2, p30
Academic Journal
The article focuses on a study which revealed that an early invasive strategy was not better than a selectively invasive strategy for acute coronary syndromes. In this study, all patients received aspirin and enoxaparin, as well as abciximab during PCI. It is uncertain to what extent the aggressive medical therapy, high revascularization rate or recruitment of low-risk patients may have contributed to the low 1-year mortality or findings of nonsuperiority of the early invasive approach.


Related Articles

  • Drugs are as good as PCI in stable coronary artery disease. Mayor, Susan // BMJ: British Medical Journal (International Edition);4/7/2007, Vol. 334 Issue 7596, p713 

    The article states that a drug treatment with lifestyle intervention offers no less risk of death, myocardial infarction, or cardiovascular events than percutaneous coronary intervention for patients with stable coronary artery disease. This finding was achieved through a prospective study,...

  • Association between Aspirin Therapy and Clinical Outcomes in Patients with Non-Obstructive Coronary Artery Disease: A Cohort Study. Hwang, In-Chang; Jeon, Joo-Yeong; Kim, Younhee; Kim, Hyue Mee; Yoon, Yeonyee E.; Lee, Seung-Pyo; Kim, Hyung-Kwan; Sohn, Dae-Won; Sung, Jidong; Kim, Yong-Jin // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Background: Presence of non-obstructive coronary artery disease (CAD) is associated with increased prescription of cardiovascular preventive medications including aspirin. However, the association between aspirin therapy with all-cause mortality and coronary revascularization in this population...

  • New Technologies in Coronary Artery Surgery. Taggart, David; Nir, Rony-Reuven; Bolotin, Gil // Rambam Maimonides Medical Journal;Jul2013, Vol. 4 Issue 3, p1 

    Coronary artery disease remains the leading cause of death in developed countries. Major recent studies such as SYNTAX and FREEDOM have confirmed that coronary artery bypass grafting (CABG) remains the gold standard treatment in terms of survival and freedom from myocardial infarction and the...

  • American Diabetes Association.  // BioWorld Today;6/9/2009, Vol. 20 Issue 109, p10 

    The article focuses on research by the National Institutes of Health (NIH) on the effectiveness of optimal medical therapy for patients with diabetes and stable coronary heart disease. The results showed the effectiveness of the therapy in lowering the risk of death, heart attack and stroke...

  • CABG beats PCI in Diabetics with Multivessel CAD. Boyle, Andrew J. // Clinical Cardiology Alert;Feb2013, Vol. 32 Issue 2, p9 

    An abstract of the article "Strategies for multivessel revascularization in patients with diabetes," by M. E. Farkouh and colleagues is presented.

  • Is no news good news? Organized follow-up, an absolute necessity for the evaluation of myocardial revascularization Wouters, Constantijn W.; Noyez, Luc // European Journal of Cardio-Thoracic Surgery;Oct2004, Vol. 26 Issue 4, p667 

    Objective: The objective of this study is to find out whether follow-up information is registered by a non-organized follow-up representative for mortality and morbidity after myocardial revascularization. Methods: The follow-up information registered by an organized (OFU) and a non-organized...

  • Why transradial instead of transfemoral approach for the percutaneous coronary intervention. Pintarić, Hrvoje // Cardiologia Croatica;Mar/Apr2014, Vol. 9 Issue 3/4, p108 

    Despite the fact that transradial approach (TRA) requires a longer learning curve than transfemoral approach (TFA), the transradial challenges are usually overcome with experience. Nowadays, in view of its benefits, there is no longer any justification for ignoring the transradial approach....

  • Aspirin benefits patients with stroke--but only just. Kmietowicz, Zosia // BMJ: British Medical Journal (International Edition);06/07/97, Vol. 314 Issue 7095, p1646 

    Discusses the therapeutic benefits that stroke patients derive from aspirin. Drop in recurrent ischemic strokes among patients administered heparin; Bias against heparin in the international stroke trial.

  • GP challenges use of aspirin for CHD.  // Pulse;6/24/2002, Vol. 62 Issue 25, p12 

    Reports on the challenge posed by British general practitioner Matthew Kiln on the use of long-term aspirin for patients with coronary heart disease. Issue raised by Kiln.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics